FCS Physicians Drs. Lucio Gordan, Manish Patel & Lowell Hart Provide Leadership at ION’s Precision Medicine Summit for Community Oncology

Fort Myers, FL – December 7, 2018 . . . Florida Cancer Specialists FCS Physicians Drs. Lucio Gordan (Gainesville),Manish Patel (Sarasota) and Lowell Hart (Fort Myers) were all invited speakers at the recent ION Precision Medicine Summit for Community Oncology, held in Charlotte, NC in early September. Natasha Khrystolubova, Clinical Pharmacy Manager for Rx To Go, the FCS in-house specialty pharmacy, was also an invited speaker. In addition to being a speaker, Dr. Gordan, who was recently named President and Managing Physician for Florida Cancer Specialists, also served as the organizer and moderator for the Summit, which provided new information and discussion about Precision Medicine as it applies to community oncology practices.  The two-day conference was sponsored by ION Solutions, a part of AmerisourceBergen, and the largest physician service organization and group purchasing organization specializing in community oncology.

ION convened an expert panel of oncologists, pharmacists, nurses and administrative staff, chaired by FCS Founder and President Emeritus Dr. William Harwin, to develop guidelines for genetic and genomic testing, which were presented at the Summit. According to ION, “Community oncology practices will now be able to better determine when and how to test appropriately, manage the challenges of payer reimbursement for testing and, ultimately, connect patients with the most effective personalized treatments.”

Dr. Harwin said of the new guidelines, “These recommendations are vital in helping community oncologists stay abreast of the latest updates in precision medicine and the growing number of genomic and genetic tests that can impact care.”

Dr. Gordan added, “Researchers anticipate that by 2025 more than 50% of oncology therapies will require some type of genetic testing. These new guidelines, which currently cover six disease states, are a true turning point for practices that are planning to provide more personalized care to their patients.”

For more information:  IONonline.com


About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) is the largest independent medical oncology/hematology practice in the United States. With more than 220 physicians, 200 advanced practice registered nurses (APRN) and physician assistants (PA) and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings close to home. 

Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. In the past 3 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report. Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in the state's leading hospitals.

FCS serves patients on the Gulf Coast from Naples to the greater Tampa Bay area, north as far as Tallahassee, in Orlando and surrounding Central Florida communities, and on the East Coast from Palm Beach County to the Jacksonville area.

Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help advance targeted treatments and genetically-based immunotherapies, and embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.
* Prior to approval

For More Information, Contact:

Florida Cancer Specialists & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer 

Christine Turner, APR

Ganick Communications, Inc.
Elaine Ganick - elaine@ganick.com